The course of emotional distress and late mortality following myocardial infarction: Implications for depression screening and treatment

Abstract

Get full access to this article

View all access options for this article.

References

Carney

Freedland

. Depression and coronary heart disease. Nat Rev Cardiol 2017; 14: 145–155.

Celano

Millstein

Bedoya

, et al. Association between anxiety and mortality in patients with coronary artery disease: a meta-analysis. Am Heart J 2015; 170: 1105–1115.

Meijer

Conradi

Bos

, et al. Prognostic association of depression following myocardial infarction with mortality and cardiovascular events: a meta-analysis of 25 years of research. Gen Hosp Psychiatry 2011; 33: 203–216.

Roest

Martens

Denollet

, et al. Prognostic association of anxiety post myocardial infarction with mortality and new cardiac events: a meta-analysis. Psychosom Med 2010; 72: 563–569.

Lichtman

Froelicher

Blumenthal

, et al. Depression as a risk factor for poor prognosis among patients with acute coronary syndrome: systematic review and recommendations: a scientific statement from the American Heart Association. Circulation 2014; 129: 1350–1369.

Vaccarino V, Badimon L, Bremner JD, et al. Depression and coronary heart disease: 2018 ESC position paper of the working group of coronary pathophysiology and microcirculation developed under the auspices of the ESC Committee for Practice Guidelines. Eur Heart J. Epub ahead of print 28 January 2019. DOI: 10.1093/eurheartj/ehy913.

Lissǻker

Norlund

Wallert

, et al. Persistent emotional distress after a first time myocardial infarction and its association to cardiovascular and noncardiovascular mortality. Eur J Prev Cardiol. 2019; 26: 1510–1518.

Nicholson

Kuper

Hemingway

. Depression as an aetiologic and prognostic factor in coronary heart disease: a meta-analysis of 6362 events among 146 538 participants in 54 observational studies. Eur Heart J 2006; 27: 2763–2774.

Kaptein

de Jonge

van den Brink

, et al. Course of depressive symptoms after myocardial infarction and cardiac prognosis: a latent class analysis. Psychosom Med 2006; 68: 662–668.

10.

Richards

Anderson

Jenkinson

, et al. Psychological interventions for coronary heart disease: Cochrane systematic review and meta-analysis. Eur J Prev Cardiol 2018; 25: 247–259.

11.

Blumenthal

Sherwood

Babyak

, et al. Exercise and pharmacological treatment of depressive symptoms in patients with coronary heart disease: results from the UPBEAT (Understanding the Prognostic Benefits of Exercise and Antidepressant Therapy) study. J Am Coll Cardiol 2012; 60: 1053–1063.

12.

Kim

Bae

Stewart

, et al. Escitalopram treatment for depressive disorder following acute coronary syndrome: a 24-week double-blind, placebo-controlled trial. J Clin Psychiatry 2015; 76: 62–68.

13.

Carney

Freedland

. Treatment-resistant depression and mortality after acute coronary syndrome. Am J Psychiatry 2009; 166: 410–417.

14.

DiMatteo

Lepper

Croghan

. Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence. Arch Intern Med 2000; 160: 2101–2107.

15.

Rieckmann

Gerin

Kronish

, et al. Course of depressive symptoms and medication adherence after acute coronary syndromes: an electronic medication monitoring study. J Am Coll Cardiol 2006; 48: 2218–2222.